Join
Live feed
·
PRReleasevia Quantisnow
Marinus Pharmaceuticals Inc. logo

Marinus Pharmaceuticals Announces Delay to RAISE Phase 3 Clinical Trial in Status Epilepticus and Associated IV Ganaxolone Clinical Trials

ByQuantisnow·Wall Street's wire, on your screen.
MRNS· Marinus Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRNS (Marinus Pharmaceuticals Inc.) and more on Quantisnow.